EMA — authorised 20 April 2007
- Marketing authorisation holder: Pfizer Europe MA EEIG
- Status: approved
EMA authorised Toviaz on 20 April 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 20 April 2007.
Pfizer Europe MA EEIG holds the EU marketing authorisation.